Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Trading Update

12 Aug 2013 07:00

RNS Number : 4221L
PROACTIS Holdings PLC
12 August 2013
 



Date:

12 August 2013

On behalf of: 

PROACTIS Holdings PLC ("Proactis" the "Company" or "the Group")

Embargoed until:

0700hrs

 

 

PROACTIS Holdings PLC

Trading Update

 

PROACTIS Holdings PLC, a global Spend Control and eProcurement solution provider, is pleased to update the market on trading for the financial year ended 31 July 2013. The Group confirms that results are expected to be in line with current market expectations, with revenues of £8.0m, adjusted EBITDA of £1.3m and adjusted profit before tax of £0.6m.

 

The Group's cash position at the end of July was approximately £2.4m and the Group remains debt free.

 

The Group starts the new financial year with an order book in excess of £6.0m and a healthy pipeline of new deal opportunities. The Board is confident of the continuing prospects for growth for the coming year.

 

The Group's results for the year ended 31 July 2013 will be announced on or around Wednesday 2 October 2013.

 

Rod Jones, Chief Executive commented:

 

"The past year has been significant for PROACTIS. With our shift toward a blended SaaS/Cloud and perpetual licensed business model just completing its third full year, we are seeing the realisation of the reliable profits that we had planned for. Our commitment to building an enhanced product remains and we are continuing to receive plaudits from the market on its breadth and depth. Our pipeline of prospects remains solid and we are confident that we will extend our already strong position within the Spend and eProcurement market place".

 

 

End

 

For further information, please contact:

 

PROACTIS Holdings PLC

Rod Jones, Chief Executive Officer

Tim Sykes, Chief Financial Office

 

Via Redleaf Polhill

 

Redleaf Polhill

Rebecca Sanders-Hewett

Jenny Bahr

0207 382 4730

finnCap Limited

Charlotte Stranner

0207 220 0500

 

 

 

 

 

 

 

 

Notes to Editors:

 

PROACTIS is a leading provider of Spend Control and eProcurement solutions. Hundreds of organisations around the world use PROACTIS software and services to streamline and automate processes and obtain best value and control in procurement.

 

Source-to-contract solutions: help organisations to automate the full buying cycle from improving the way they find, evaluate and engage suppliers to increasing "on contract" spending and enabling more effective collaboration with their trading network.

 

Purchase-to-Pay solutions: enable organisations to streamline the purchase to pay process, eliminate labour-intensive manual registration of invoices, speed up invoice matching and approvals and gain control of the "after-the-event" purchase claims.

 

Widely used in mid-to-large sized organisations across private, public and not-for-profit sectors, PROACTIS is routinely integrated with ERP and financial systems. PROACTIS also offers a range of cloud-based delivery options, including Software-as-a-Service ("SaaS") and dedicated-hosted application delivery, and flexible licensing models.

 

PROACTIS was founded in 1996 and has been listed on the London Stock Exchange since 2006 (AIM: phd). Headquartered in the UK with direct operations in Europe, North America, and Asia Pacific, PROACTIS also has an extensive global partner network.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKRNROUAWRAR
Date   Source Headline
27th Mar 20137:00 amRNSInterim Results
13th Mar 20137:00 amRNSEntry into the Indian Market through Joint Venture
11th Mar 20137:00 amRNSNotice of Results
30th Jan 20139:17 amRNSPosting of Annual Report and Accounts
9th Jan 20137:00 amRNSAppointment of commercial partner
17th Dec 20125:07 pmRNSResult of AGM
13th Dec 20124:45 pmPRNStatement re Proactis Holdings plc
11th Dec 20129:21 amRNSDirector's Dealing
4th Dec 20127:00 amRNSDirectorate Change
7th Nov 20127:00 amRNSDirector/PDMR Shareholding and Issue of Equity
26th Sep 20127:00 amRNSPreliminary Results for year ended 31 July 2012
13th Aug 20127:00 amRNSTrading Update
16th Jul 20127:02 amRNSPartnership with Civica
22nd Mar 20127:00 amRNSHalf Yearly Report
5th Mar 20127:00 amRNSPartnership with Eclipse
26th Jan 20127:00 amRNSGrant of Options
19th Dec 20114:31 pmRNSResult of AGM
1st Dec 20117:00 amRNSNotice of AGM & Report and Accounts
27th Oct 20117:00 amRNSPreliminary Results for the year to 31 July 2011
4th Aug 20117:00 amRNSTrading Update
5th Apr 20117:01 amRNSInterim results for six months to 31 January 2011
5th Apr 20117:00 amRNSChange of Adviser
30th Mar 20114:25 pmRNSIssue of Equity
7th Jan 20117:00 amRNSGrant of Options
20th Dec 20104:30 pmRNSResult of AGM
21st Oct 20107:00 amRNSPROACTIS signs Fortune 100 customer
21st Oct 20107:00 amRNSPROACTIS signs Fortune 100 customer
29th Sep 20107:00 amRNSPreliminary Results for the year to 31 July 2010
13th Aug 20107:00 amRNSTrading Update
22nd Jun 20104:31 pmRNSDirector/PDMR Shareholding
13th Apr 20107:00 amRNSHalf Yearly Report
17th Feb 20108:47 amRNSHolding(s) in Company
16th Feb 20101:56 pmRNSHolding(s) in Company
11th Feb 20107:00 amRNSDirector/PDMR Shareholding
3rd Feb 20109:57 amRNSDirectorate Change
21st Dec 20094:01 pmRNSResult of AGM and Posting of Accounts
6th Nov 20097:00 amRNSTransaction in Own Shares
6th Nov 20097:00 amRNSExercise of Options/Issue of Equity
30th Oct 20095:18 pmRNSCorrection - Transaction in own Shares
30th Oct 20092:21 pmRNSTransaction in Own Shares
26th Oct 200912:25 pmRNSTransaction in Own Shares
30th Sep 20097:00 amRNSPreliminary Results to Year ending 31 July 2009
7th Apr 20097:00 amRNSHalf Yearly Report
2nd Feb 20098:15 amRNSDirector/PDMR Shareholding
26th Jan 20097:00 amRNSResult of AGM and Posting of Accounts
20th Jan 200912:38 pmRNSDirector/PDMR Shareholding
26th Nov 200810:11 amRNSExercise of Options
4th Nov 20081:59 pmRNSDirector/PDMR Shareholding
30th Sep 20087:00 amRNSGrant of Options
30th Sep 20087:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.